Prevalence of metabolic syndrome in women with polycystic ovary syndrome attending a tertiary care hospital in West Delhi, India

Background: The aim of the present study was to evaluate the prevalence of metabolic syndrome in women with polycystic ovary syndrome (PCOS). Methods: All the women attending the gynae out-patient department of our hospital were screened for polycystic ovary syndrome as diagnosed by the Rotterdam ES...

Full description

Saved in:
Bibliographic Details
Published inInternational Journal of Reproduction, Contraception, Obstetrics and Gynecology Vol. 8; no. 3; p. 1127
Main Authors Laul, Poonam, Miglani, Urvashi, Laul, Anish, Saxena, Pinkee, Malhotra, Megha, Kadam, V.K
Format Journal Article
LanguageEnglish
Published International Journal of Reproduction, Contraception, Obstetrics and Gynecology 01.03.2019
Subjects
Body mass index
Cholesterol
Complications and side effects
Corporate sponsorship
Medical research
Metabolic syndrome X
Obesity
Polycystic ovary syndrome
Regression analysis
Risk factors
Statistics
Type 2 diabetes
Workshops (Educational programs)
India
Online AccessGet full text

Cover

More Information
Summary:Background: The aim of the present study was to evaluate the prevalence of metabolic syndrome in women with polycystic ovary syndrome (PCOS). Methods: All the women attending the gynae out-patient department of our hospital were screened for polycystic ovary syndrome as diagnosed by the Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group, 2004. Two hundred women with PCOS underwent screening for metabolic syndrome as defined by the national cholesterol education program adult treatment panel III (ATPIII) (2001) definition and the prevalence of metabolic syndrome was compared with two hundred age and BMI matched healthy control subjects. A multivariate logistic regression analysis was applied, and significant predictors identified for the prediction of metabolic syndrome. Results: The prevalence of metabolic syndrome among PCOS patients was 42 % in present study group as compared to 14 % in control group (p=0.01). The prevalence of metabolic syndrome was even higher in obese PCOS Vs non obese PCOS (52 % Vs 28.6 %). But even non-obese PCOS had higher prevalence of metabolic syndrome as compared to controls (28.6 % Vs 14 %). Conclusions: The study suggests a high prevalence of metabolic syndrome in patients with PCOS & thus it is important to screen all PCOS patients for manifestations of metabolic syndrome & its cardiovascular sequelae. Keywords: Metabolic syndrome, Polycystic ovary syndrome, Screening
ISSN:2320-1770
2320-1789
DOI:10.18203/2320-1770.ijrcog20190892